(Q44762095)

English

Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment

scientific article published on 21 October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Xing Lv

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Yan-Qun Xiang

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Su-Mei Cao

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Chao-Nan Qian

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Ning-Wei Li

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Ling Guo

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Hai-Qiang Mai

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Qiu-Yan Chen

8

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Pei-Yu Huang

9

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

DongHua Luo

10

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Ka-Jia Cao

11

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Ming-Huang Hong

12

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Xiang Guo

13

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

21 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

780-785

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Vascular endothelial growth factor is a secreted angiogenic mitogen

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

21 January 2018

Hypoxia-induced angiogenesis during carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

21 January 2018

The clinical significance of coexpression of cyclooxygenases-2, vascular endothelial growth factors, and epidermal growth factor receptor in nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

21 January 2018

Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status.

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

21 January 2018

Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

21 January 2018

VEGF concentrations in tumour arteries and veins from patients with rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

21 January 2018

Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

21 January 2018

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

21 January 2018

Sorafenib in advanced clear-cell renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

21 January 2018

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

21 January 2018

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

21 January 2018

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

21 January 2018

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

21 January 2018

Vascular permeability factor, an endothelial cell mitogen related to PDGF

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of vascular endothelial growth factor expression with angiogenesis and lymph node metastasis in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

7 January 2021

based on heuristic

inferred from DOI database lookup

Human neutrophils secrete vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of tissue and serum VEGF in patients with head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

7 January 2021

based on heuristic

inferred from DOI database lookup

High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

7 January 2021

based on heuristic

inferred from DOI database lookup

The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis

1 reference

https://api.crossref.org/works/10.1002%2FHED.21541

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HED.21541

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44762095&oldid=2039442395"